1. Home
  2. ADNT vs PAHC Comparison

ADNT vs PAHC Comparison

Compare ADNT & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adient plc

ADNT

Adient plc

HOLD

Current Price

$21.22

Market Cap

1.7B

ML Signal

HOLD

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$39.95

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADNT
PAHC
Founded
2016
1946
Country
Ireland
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ADNT
PAHC
Price
$21.22
$39.95
Analyst Decision
Hold
Hold
Analyst Count
10
4
Target Price
$23.10
$31.25
AVG Volume (30 Days)
1.3M
199.5K
Earning Date
02-04-2026
02-04-2026
Dividend Yield
N/A
1.24%
EPS Growth
N/A
288.74
EPS
N/A
1.67
Revenue
$14,535,000,000.00
$1,399,676,000.00
Revenue This Year
$1.86
$15.34
Revenue Next Year
$2.20
$3.28
P/E Ratio
N/A
$23.23
Revenue Growth
N/A
33.72
52 Week Low
$10.04
$16.16
52 Week High
$26.16
$46.42

Technical Indicators

Market Signals
Indicator
ADNT
PAHC
Relative Strength Index (RSI) 51.31 51.36
Support Level $21.18 $38.50
Resistance Level $22.45 $39.91
Average True Range (ATR) 0.97 1.38
MACD -0.06 -0.03
Stochastic Oscillator 30.93 39.40

Price Performance

Historical Comparison
ADNT
PAHC

About ADNT Adient plc

Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: